可溶性细胞因子受体及基质金属蛋白酶与胰腺癌的关系
Relationship between Soluble Cytokine Receptors, Matrix Metalloproteinases and Pancreatic Cancer
-
摘要: 目的 探究可溶性细胞因子受体及基质金属蛋白酶与胰腺癌的关系.方法 选取2014年4月至2016年5月期间西双版纳州人民医院收治的59例胰腺癌患者为观察组, 并选取同时间段同龄的59名体检显示健康的人员为对照组, 检测与比较对照组和观察组的血清可溶性细胞因子受体及基质金属蛋白酶相关指标水平, 然后比较观察组中不同Hemrick分期及病理分类患者的检测结果, 以Logistic分析可溶性细胞因子受体及基质金属蛋白酶与胰腺癌的关系.结果 观察组的血清可溶性细胞因子受体及基质金属蛋白酶相关指标水平均高于对照组, 且Hemrick分期较高患者的检测水平高于Hemrick分期较低的患者, P<0.05, 但是不同病理分类患者的检测水平差异无统计学意义, P>0.05, 经Logistic分析显示, 可溶性细胞因子受体及基质金属蛋白酶均与胰腺癌有密切的关系.结论 胰腺癌患者的可溶性细胞因子受体及基质金属蛋白酶呈现高表达状态, 且对于Hemrick分期也有一定的反应价值, 因此对胰腺癌患者进行上述指标的监测价值较高.Abstract: Objective To investigate the relationship between soluble cytokine receptors, matrix metalloproteinases and pancreatic cancer.Methods Fifty-nine patients with pancreatic cancer in our hospital from April 2014 to May 2016 were selected in the observation group, 59 healthy subjects were selected in the control group, then the serum soluble cytokine receptors and matrix metalloproteinases levels of control group and observation group were detected and compared, and the detection results of observation group with different Hemrick stages and pathological classifications were compared, then the relationship between soluble cytokine receptors, matrix metalloproteinases and pancreatic cancer were analyzed by the Logistic analysis.Results The serum soluble cytokine receptors and matrix metalloproteinases levels of observation group were all higher than the levels of control group, the detection levels of patients with higher Hemrick stages were all higher than the levels of patients with lower Hemrick stages, all P <0.05, while the detection levels of patients with different pathological classifications had no obvious differences, all P >0.05, the Logistic analysis showed that the soluble cytokine receptors and matrix metalloproteinases all had close relationship to the pancreatic cancer.Conclusion Thesoluble cytokine receptors and matrix metalloproteinases of patients with pancreatic cancer show higher expression state, and have a indication value for the Hemrick staging, these indexes have high monitoring value for pancreatic cancer.
-
Key words:
- Soluble cytokine receptors /
- Matrix metalloproteinases /
- Pancreatic cancer
-
[1]党诚学, 刁冬梅.胰腺癌神经浸润相关分子表达及作用的研究进展[J].西安交通大学学报:医学版, 2014, 35 (1) :1-5. [2]陈文政, 刘国才, 臧辉, 等.GLI1和MMP9在胰腺癌中的表达及其临床意义的研究[J].辽宁医学杂志, 2015, 29 (4) :207-211. [3]田峰, 方瑞忠, 徐建.基质金属蛋白酶-2和E-钙黏蛋白在胰腺癌组织中的表达及临床意义[J].中国现代医学杂志, 2016, 26 (9) :34-38. [4]李秋婷, 康举龄, 吴先林.基质金属蛋白酶-2与胰腺癌关系的研究进展[J].广东医学, 2016, 37 (7) :1082-1084. [5] [5]ROOMI M W, KALINOVSKY T, NIEDZWIECKI A, et al.Modulation of u PA, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines[J].Int J Oncol, 2015, 47 (1) :370-376. [6]苏春永, 霍华治, 杨晓光.胰腺癌组织COX-2、VEGF、MMP-9的表达及塞来布昔对人胰腺癌BXPC-3细胞VEGF、MMP-9表达的影响[J].河北医药, 2015, 37 (21) :3205-3028. [7]虞昆, 吴育连.胰腺癌患者外周血清IL-2、s IL-2R、IL-6、IL-8水平测定研究[J].基层医学论坛, 2006, 10 (10) :867-868. [8] 谭劲赟, 孟蔚韦华.胰腺癌患者血清中糖类抗原199和基质金属蛋白酶-2的表达及意义[J].海南医学院学报, 2011, 17 (9) :1164-1166. [9]曾强, 巩燕.胰腺癌血清学标记物在胰腺癌初期诊断中的研究进展[J].解放军医学院学报, 2015, 36 (2) :184-186. [10] [10]PIETKIEWICZ S, EILS R, KRAMMER P H, et al.Combinatorial treatment of CD95L and gemcitabine in pancreatic cancer cells induces apoptotic and RIP1-mediated necroptotic cell death network[J].Exp Cell Res, 2015, 339 (1) :1-9.
点击查看大图
计量
- 文章访问数: 2625
- HTML全文浏览量: 1019
- PDF下载量: 44
- 被引次数: 0